334 related articles for article (PubMed ID: 36613792)
1. Preclinical and Clinical Applications of Metabolomics and Proteomics in Glioblastoma Research.
Ahmed M; Semreen AM; El-Huneidi W; Bustanji Y; Abu-Gharbieh E; Alqudah MAY; Alhusban A; Shara M; Abuhelwa AY; Soares NC; Semreen MH; Alzoubi KH
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613792
[TBL] [Abstract][Full Text] [Related]
2. Proteomic and metabolomic signatures of U87 glioblastoma cells treated with cisplatin and/or paclitaxel.
Ahmed M; Semreen AM; Giddey AD; Ramadan WS; El-Awady R; Soares NC; El-Huneidi W; Bustanji Y; Alqudah MAY; Alzoubi KH; Semreen MH
Ann Med; 2023; 55(2):2305308. PubMed ID: 38253025
[TBL] [Abstract][Full Text] [Related]
3. Pharmacometabolomics Informs Quantitative Radiomics for Glioblastoma Diagnostic Innovation.
Katsila T; Matsoukas MT; Patrinos GP; Kardamakis D
OMICS; 2017 Aug; 21(8):429-439. PubMed ID: 28816643
[TBL] [Abstract][Full Text] [Related]
4. Metabolomics and Proteomics in Prostate Cancer Research: Overview, Analytical Techniques, Data Analysis, and Recent Clinical Applications.
Al-Daffaie FM; Al-Mudhafar SF; Alhomsi A; Tarazi H; Almehdi AM; El-Huneidi W; Abu-Gharbieh E; Bustanji Y; Alqudah MAY; Abuhelwa AY; Guella A; Alzoubi KH; Semreen MH
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791108
[TBL] [Abstract][Full Text] [Related]
5. Integrative cross-platform analyses identify enhanced heterotrophy as a metabolic hallmark in glioblastoma.
Prabhu AH; Kant S; Kesarwani P; Ahmed K; Forsyth P; Nakano I; Chinnaiyan P
Neuro Oncol; 2019 Feb; 21(3):337-347. PubMed ID: 30476237
[TBL] [Abstract][Full Text] [Related]
6. Proteomics, metabolomics and metagenomics for type 2 diabetes and its complications.
Wang N; Zhu F; Chen L; Chen K
Life Sci; 2018 Nov; 212():194-202. PubMed ID: 30243649
[TBL] [Abstract][Full Text] [Related]
7. Metabolomics Approach Reveals Important Glioblastoma Plasma Biomarkers for Tumor Biology.
Ferrasi AC; Puttini R; Galvani AF; Hamamoto Filho PT; Delafiori J; Argente VD; de Oliveira AN; Dias-Audibert FL; Catharino RR; Silva OC; Zanini MA; Kurokawa GA; Lima EO
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240159
[TBL] [Abstract][Full Text] [Related]
8. [Multi-omics technology and its applications to life sciences: a review].
Liu J; Li W; Wang L; Li J; Li E; Luo Y
Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3581-3593. PubMed ID: 36305394
[TBL] [Abstract][Full Text] [Related]
9. Metabolomics enables precision medicine: "A White Paper, Community Perspective".
Beger RD; Dunn W; Schmidt MA; Gross SS; Kirwan JA; Cascante M; Brennan L; Wishart DS; Oresic M; Hankemeier T; Broadhurst DI; Lane AN; Suhre K; Kastenmüller G; Sumner SJ; Thiele I; Fiehn O; Kaddurah-Daouk R;
Metabolomics; 2016; 12(10):149. PubMed ID: 27642271
[TBL] [Abstract][Full Text] [Related]
10. The Application of Omics Technologies in the Research of Neurotoxicology.
Shao W; Li H
Methods Mol Biol; 2021; 2326():143-154. PubMed ID: 34097266
[TBL] [Abstract][Full Text] [Related]
11. Integration of metabolomics and proteomics in multiple sclerosis: From biomarkers discovery to personalized medicine.
Del Boccio P; Rossi C; di Ioia M; Cicalini I; Sacchetta P; Pieragostino D
Proteomics Clin Appl; 2016 Apr; 10(4):470-84. PubMed ID: 27061322
[TBL] [Abstract][Full Text] [Related]
12. Proteomic and Metabolomic Profiling in Soft Tissue Sarcomas.
Chadha M; Huang PH
Curr Treat Options Oncol; 2022 Jan; 23(1):78-88. PubMed ID: 35171456
[TBL] [Abstract][Full Text] [Related]
13. Integrative Proteomics-Metabolomics Strategy for Pathological Mechanism of Vascular Depression Mouse Model.
Zhao H; Du H; Liu M; Gao S; Li N; Chao Y; Li R; Chen W; Lou Z; Dong X
J Proteome Res; 2018 Jan; 17(1):656-669. PubMed ID: 29190102
[TBL] [Abstract][Full Text] [Related]
14. Data analysis methods for defining biomarkers from omics data.
Li C; Gao Z; Su B; Xu G; Lin X
Anal Bioanal Chem; 2022 Jan; 414(1):235-250. PubMed ID: 34951658
[TBL] [Abstract][Full Text] [Related]
15. Current and Future Trends on Diagnosis and Prognosis of Glioblastoma: From Molecular Biology to Proteomics.
Silantyev AS; Falzone L; Libra M; Gurina OI; Kardashova KS; Nikolouzakis TK; Nosyrev AE; Sutton CW; Mitsias PD; Tsatsakis A
Cells; 2019 Aug; 8(8):. PubMed ID: 31405017
[TBL] [Abstract][Full Text] [Related]
16. Single-platform 'multi-omic' profiling: unified mass spectrometry and computational workflows for integrative proteomics-metabolomics analysis.
Blum BC; Mousavi F; Emili A
Mol Omics; 2018 Oct; 14(5):307-319. PubMed ID: 30211418
[TBL] [Abstract][Full Text] [Related]
17. OMICS insights into cancer histology; Metabolomics and proteomics approach.
Tayanloo-Beik A; Sarvari M; Payab M; Gilany K; Alavi-Moghadam S; Gholami M; Goodarzi P; Larijani B; Arjmand B
Clin Biochem; 2020 Oct; 84():13-20. PubMed ID: 32589887
[TBL] [Abstract][Full Text] [Related]
18. The "-OMICS" facet of melanoma: Heterogeneity of genomic, proteomic and metabolomic biomarkers.
Donnelly D; Aung PP; Jour G
Semin Cancer Biol; 2019 Dec; 59():165-174. PubMed ID: 31295564
[TBL] [Abstract][Full Text] [Related]
19. Glioblastoma Metabolomics-In Vitro Studies.
Jaroch K; Modrakowska P; Bojko B
Metabolites; 2021 May; 11(5):. PubMed ID: 34068300
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
